Global Burden of Respiratory Syncytial Virus
A special issue of Infectious Disease Reports (ISSN 2036-7449). This special issue belongs to the section "Viral Infections".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 2324
Special Issue Editor
Special Issue Information
Dear Colleagues,
As a suite of promising new RSV prophylactics come to market, policymakers need to be able to accurately evaluate the impact of these products in order to determine what intervention programs are cost-effective. Having reliable estimates for the disease burden of RSV across a study population is therefore essential in ensuring the impact of these potential programs is accurately evaluated. However, estimating the global burden of RSV can be difficult, as many cases and deaths occur outside of a clinical interface and in places with limited access to molecular testing. Consequently, there is an ongoing global effort to better understand the disease burden of RSV, particularly in LMICs.
This Special Issue of Infectious Disease Reports will shine light on important epidemiological studies which estimate the disease burden of RSV at national, regional, and local levels across the globe. This includes prospective and retrospective cohort studies, case-control studies, and cross-sectional studies. We are particularly interested in measures of severe disease burden (including hospitalizations and deaths) in LMICs, and the impact infant infections have on their carers. Original research articles, reviews, and short reports are welcome for submission.
Dr. David Hodgson
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Infectious Disease Reports is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- RSV
- disease burden
- LMICs
- indirect effects
- longitudinal studies
- retrospective studies
- vaccine impact
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
